Estrella Immunopharma, Inc.
ESLANasdaqCIK 1844417HealthcareFiscal year ends Dec 31
Reports and events: 105 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2917:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-113912 |
| 2026-09-0817:25 ET | 8-K | 3.01 Delisting notice | 0001213900-26-098123 |
| 2026-08-2117:00 ET | 8-K | 3.01 Delisting notice | 0001213900-26-092657 |
| 2026-08-1317:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-089215 |
| 2026-06-3017:29 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-073847 |
| 2026-05-2717:25 ET | DEF 14A | Proxy statementPeriod 2026-06-29 | 0001140361-26-023012 |
| 2026-05-1821:26 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-058063 |
| 2026-04-3017:27 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001213900-26-050433 |
| 2026-03-1820:53 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-029357 |
| 2026-01-2220:51 ET | S-1/A | Registration statement, amended | 0001213900-26-006410 |
| 2026-01-1617:08 ET | S-1/A | Registration statement, amended | 0001213900-26-005233 |
| 2026-01-1317:21 ET | 8-K | 3.01 Delisting notice | 0001213900-26-003998 |
| 2026-01-0616:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-001777 |
| 2025-12-2210:56 ET | S-1 | Registration statement | 0001213900-25-124247 |
| 2025-12-0409:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-118097 |
| 2025-11-1216:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109198 |
| 2025-11-0617:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-107249 |
| 2025-09-2917:15 ET | 8-K | 8.01 Other events | 0001213900-25-093197 |
| 2025-09-2617:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-092471 |
| 2025-08-1221:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-074567 |
| 2025-08-0720:32 ET | 8-K | 3.01 Delisting notice | 0001213900-25-072746 |
| 2025-06-0508:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-051361 |
| 2025-06-0308:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-050329 |
| 2025-05-2911:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-048597 |
| 2025-05-1416:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043365 |
| 2025-05-0217:00 ET | 8-K | 3.01 Delisting notice | 0001213900-25-039261 |
| 2025-02-2108:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-015851 |
| 2025-02-2017:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-015364 |
| 2024-12-1616:00 ET | 8-K | 8.01 Other events | 0001213900-24-109285 |
| 2024-12-0609:12 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-106238 |
| 2024-11-2617:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-102899 |
| 2024-11-2516:00 ET | 8-K | 3.01 Delisting notice | 0001213900-24-102134 |
| 2024-11-1416:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098450 |
| 2024-11-0717:27 ET | 8-K/A | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-095507 |
| 2024-11-0717:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-095506 |
| 2024-10-2817:03 ET | 10-K/A | Annual report, amendedPeriod 2024-06-30 | 0001213900-24-091250 |
| 2024-09-2719:50 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001213900-24-082374 |
| 2024-08-2017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-071174 |
| 2024-08-0618:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-065292 |
| 2024-07-0219:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-058085 |
| 2024-05-1521:49 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-043126 |
| 2024-05-1317:28 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-042444 |
| 2024-04-1006:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-031716 |
| 2024-03-1121:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-021186 |
| 2024-03-0721:49 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-020566 |
| 2024-02-1417:28 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001213900-24-014191 |
| 2024-02-0208:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-24-009325 |
| 2024-01-3011:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-007723 |
| 2023-12-1821:58 ET | S-1/A | Registration statement, amended | 0001213900-23-096259 |
| 2023-11-2017:12 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-088827 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.